Cellulitis

Crimean–Congo hemorrhagic fever (CCHF) is a widespread tick-borne viral disease. The virus is a member of the Bunyaviridae family of RNA viruses. It is a zoonotic disease carried by several domestic and wild animals. While clinical disease is rare in infected animals, it is severe in infected humans, with a mortality rate of 10-40%. Outbreaks of illness are usually attributable to Hyalomma tick bites or contact with infected animals or people. The virus is primarily transmitted to people from ticks and livestock animals. Human-to-human transmission can occur resulting from close contact with the blood, secretions, organs or other bodily fluids of infected persons. The symptoms include mood instability, agitation, mental confusion and throat petechiae, then soon nosebleeds, rainbow urine and vomiting, and black stools. The liver becomes swollen and painful. Disseminated intravascular coagulation may occur as well as acute kidney failure and shock, and sometimes acute respiratory distress syndrome. Patients usually begin to show signs of recovery after 9–10 days from when the symptoms appear, however 30% of the cases result in death on the second week of the illness.

Trauma to the skin Diabetes Circulatory problems, such as not enough blood flow to your arms and legs, poor drainage of your veins or lymphatic system, or varicose veins -- twisted, enlarged veins near the surface of the skin Liver disease such as chronic hepatitis or cirrhosis Skin disorders such as eczema, psoriasis, or infectious diseases that cause sores, such as chickenpox

Rest the area. Elevate the area to help reduce swelling and relieve discomfort. Use over-the-counter pain relievers such as acetaminophen (Tylenol) or ibuprofen (Motrin) to ease the pain, as well as keep your fever down. 1 2

Factors associated with prolonged admission included admission to or consultation by a surgical service (OR 2.30, 95% CI 2.17-2.43) and dermatology consultation (OR 4.50, 95% CI 3.92-5.17). Factors associated with mortality included surgical (OR 1.35, 95% CI 1.03-1.76) or infectious disease (OR 1.75, 95% CI 1.39-2.21) consultation.